Yu Tianhua, Xu Zhihua, Zhang Xuanhe, Men Lan, Nie Haiying
Department of Blood Transfusion, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.
Department of The 3rd Neurology, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.
Oncol Rep. 2022 Feb;47(2). doi: 10.3892/or.2021.8239. Epub 2021 Dec 8.
Following the publication of this paper, an interested reader drew the authors' attention to the fact that several of the tumour images shown in Fig. 6B were strikingly similar to images that had appeared in another paper by different authors published at around the same time. The authors also admitted that the in vivo experiments reported in this study had been performed by a third party. Consequently, owing to a lack of confidence in the presented data, the authors requested that this paper be retracted from the Journal. The Editor was in agreement that the paper should be retracted. All authors agree with the retraction of this article, and the Editor apologizes to the readership for any inconvenience caused. [the original article was published in Oncology Reports 40: 3763‑3771, 2018; DOI: 10.3892/or.2018.6721].
在本文发表之后,一位感兴趣的读者让作者们注意到,图6B中所示的几张肿瘤图像与大约同一时间发表的另一篇由不同作者撰写的论文中出现的图像惊人地相似。作者们还承认,本研究中报告的体内实验是由第三方进行的。因此,由于对所呈现的数据缺乏信心,作者们要求从《肿瘤学报告》撤回本文。编辑同意撤回该论文。所有作者均同意撤回本文,编辑就由此造成的不便向读者致歉。[原文发表于《肿瘤学报告》40: 3763 - 3771,2018;DOI: 10.3892/or.2018.6721]